Why is There Discordance between the Reimbursement of High-Cost ‘Life-Extending’ Pharmaceuticals and Medical Devices? The Funding of Ventricular Assist Devices in Australia Sopany SaingNaomi van der LindenStephen Goodall Current Opinion 25 March 2019 Pages: 421 - 431
Advanced Data Visualisation in Health Economics and Outcomes Research: Opportunities and Challenges Shelagh M. SzaboKarissa M. JohnstonAndrew J. Lloyd Practical Application 04 May 2019 Pages: 433 - 441
A Review of the Challenges of Using Biomedical Big Data for Economic Evaluations of Precision Medicine Patrick FahrJames BuchananSarah Wordsworth Review Article Open access 03 April 2019 Pages: 443 - 452
Mepilex Border Sacrum and Heel Dressings for the Prevention of Pressure Ulcers: A NICE Medical Technology Guidance C. MarshallJ. ShoreMichelle Jenks Review Article Open access 01 March 2019 Pages: 453 - 465
Systematic Review of Decision Analytic Modelling in Economic Evaluations of Low Back Pain and Sciatica James A. HallKika KonstantinouSue Jowett Systematic Review 03 April 2019 Pages: 467 - 491
Budget Impact Analysis of Cancer Screening: A Methodological Review Beate JahnJovan TodorovicUwe Siebert Systematic Review 24 April 2019 Pages: 493 - 511
The Costs of Hepatitis C by Liver Disease Stage: Estimates from the Veterans Health Administration Risha Gidwani-MarszowskiDouglas K. OwensPaul G. Barnett Original Research Article 27 April 2019 Pages: 513 - 521
Physical Activity and Healthcare Costs: Projections for Poland in the Context of an Ageing Population Małgorzata KalbarczykJoanna Mackiewicz-Łyziak Original Research Article Open access 28 March 2019 Pages: 523 - 532
Applying an Implementation Framework to the Use of Evidence from Economic Evaluations in Making Healthcare Decisions Gregory MerloKatie PageNicholas Graves Original Research Article 03 May 2019 Pages: 533 - 543
Willingness to Pay for Cataract Surgeries Among Patients Visiting Eye Care Facilities in Dhaka, Bangladesh Muhammed Nazmul IslamThomas EngelsAtonu Rabbani Original Research Article 07 May 2019 Pages: 545 - 554
Cost Effectiveness of the Third-Generation Tyrosine Kinase Inhibitor (TKI) Ponatinib, vs. Second-Generation TKIs or Stem Cell Transplant, as Third-Line Treatment for Chronic-Phase Chronic Myeloid Leukemia Carsten HirtSergio IannazzoJeffrey H. Lipton Original Research Article 06 June 2019 Pages: 555 - 567
Comment on: “Cost Effectiveness of Dialysis Modalities: A Systematic Review of Economic Evaluations” Salman HussainAmbrish SinghAbul Kalam Najmi Letter to the Editor 07 June 2019 Pages: 569 - 570
Authors’ Reply to Hussain et al.: “Cost Effectiveness of Dialysis Modalities: A Systematic Review of Economic Evaluations” Martin HowellRachael WalkerKirsten Howard Letter to the Editor 07 June 2019 Pages: 571 - 572